Conquering Diseases

Investigational Treatment For Moderate To Severe Crohn's Disease

Description

This study is looking at an investigational treatment for patients who have been diagnosed with or have signs and symptoms of moderately to severely active Crohn’s disease.

Overview

Crohn’s Disease is a chronic inflammatory disorder of the bowels that can cause diarrhea, abdominal pain, rectal bleeding, weight loss, and fever. The purpose of this study is to see whether the investigational study drug is safe and effective for the possible treatment of Crohn’s Disease. If you join this research, you will be randomly assigned to receive either the study drug or placebo( a pill that does not contain active ingredients).

What we're hoping for

We’re hoping the study drug is safe and effective for treating Crohn’s Disease compared to a placebo.

Additional Information

ClinicalTrials.gov Identifier: NCT03440385

 Principal Investigator

David  Cave, MD

UMass Memorial Health Care

 Study Contact

The Gastrointestinal Research  Office

774-442-4098

IBDClinicalTrials@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989